Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates

Abstract

BackgroundDue to excessive antibiotic use, drug-resistant Mycobacterium tuberculosis has become a serious public health threat and a major obstacle to disease control in many countries. To better understand the evolution of drug-resistant M. tuberculosis strains, we performed whole genome sequencing for 7 M. tuberculosis clinical isolates with different antibiotic resistance profiles and conducted comparative genomic analysis of gene variations among them.ResultsWe observed that all 7 M. tuberculosis clinical isolates with different levels of drug resistance harbored similar numbers of SNPs, ranging from 1409–1464. The numbers of insertion/deletions (Indels) identified in the 7 isolates were also similar, ranging from 56 to 101. A total of 39 types of mutations were identified in drug resistance-associated loci, including 14 previously reported ones and 25 newly identified ones. Sixteen of the identified large Indels spanned PE-PPE-PGRS genes, which represents a major source of antigenic variability. Aside from SNPs and Indels, a CRISPR locus with varied spacers was observed in all 7 clinical isolates, suggesting that they might play an important role in plasticity of the M. tuberculosis genome. The nucleotide diversity (Л value) and selection intensity (dN/dS value) of the whole genome sequences of the 7 isolates were similar. The dN/dS values were less than 1 for all 7 isolates (range from 0.608885 to 0.637365), supporting the notion that M. tuberculosis genomes undergo purifying selection. The Л values and dN/dS values were comparable between drug-susceptible and drug-resistant strains.ConclusionsIn this study, we show that clinical M. tuberculosis isolates exhibit distinct variations in terms of the distribution of SNP, Indels, CRISPR-cas locus, as well as the nucleotide diversity and selection intensity, but there are no generalizable differences between drug-susceptible and drug-resistant isolates on the genomic scale. Our study provides evidence strengthening the notion that the evolution of drug resistance among clinical M. tuberculosis isolates is clearly a complex and diversified process.Electronic supplementary materialThe online version of this article (doi: 10.1186/1471-2164-15-469) contains supplementary material, which is available to authorized users.

Draft genomes of four enterotoxigenic Escherichia coli (ETEC) clinical isolates from China and Bangladesh

“…The genome sequences of each ETEC isolate were generated using paired-end libraries with 350 ~ 400 bp inserts on an Illumina GAIIX (Illumina, San Diego, CA, USA). The detailed methods for genome assembly were described in another paper [ 14 ]. Genome sequences were annotated by using Subsystem Technology (RAST) [ 15 ].…”

Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host Lethality

“…The host, S. thermophilus, benefits from the stalling of phage multiplication and lysis, as they get an opportunity to incorporate pieces of phage DNA into their CRISPR loci, resulting in phage resistance. As of now, a CRISPR system active against mycobacteriophage D29 is not known, although the possibility of identifying one in the future cannot be ruled out, since CRISPRs have been found in mycobacterial systems (54).…”

Multidrug-Resistant Bacterial Isolates Recovered from Herbal Medicinal Products Sold in Nairobi, Kenya

“…Its primers are SulA: F-AC TGC CAC AAG CCG TAA and SulA: R-GTC CGC CTC AGC AAT ATC. 14 The DNA products were loaded on an agarose gel, and gel electrophoresis was performed to separate the mixture of DNA pellets. The DNA bands (products) were visualised using ultraviolet transmission light and were photographed alongside the controls and molecular weight markers.…”